BC can increase Ras expression but inhibit p-ERK and c-Fos expression, and we speculate that BC hinders the process of RAS conversion to RAF, allowing RAS to accumulate in cells, thereby inhibiting the Ras/ERK/c-Fos pathway. The gene discussed is FOS; the disease is breast cancer.